Aminobenzoic acids and derivatives
Aobchem Benzoic acid 4-(4 4 5 5-tetramethyl-1 3 2-dioxaborolan-2-yl)-2-(2 2 2-triflu | 95% | CAS 2098426-47-0 | C16H20BF3O5 | 500mg
Benzoic acid 4-(4 4 5 5-tetramethyl-1 3 2-dioxaborolan-2-yl)-2-(2 2 2-triflu | 95% | CAS 2098426-47-0 | C16H20BF3O5 | 500mg
Aobchem 2-Ethoxy-4 5-dimethylbenzoic acid | ≥97% | CAS 1216078-34-0 | C11H14O3 | 500mg
2-Ethoxy-4 5-dimethylbenzoic acid | ≥97% | CAS 1216078-34-0 | C11H14O3 | 500mg
Aobchem 2 3-Dichloro-6-bromobenzoic acid | ≥97% | CAS 887584-64-7 | C7H3BrCl2O2 | 500mg
2 3-Dichloro-6-bromobenzoic acid | ≥97% | CAS 887584-64-7 | C7H3BrCl2O2 | 500mg
Aobchem 2 3-Dichloro-6-bromobenzoic acid | ≥97% | CAS 887584-64-7 | C7H3BrCl2O2 | 5g
2 3-Dichloro-6-bromobenzoic acid | ≥97% | CAS 887584-64-7 | C7H3BrCl2O2 | 5g
Medchemexpress LLC HLA-A*02:01&B2M&PRAME (SLLQHLIGL) monomer protein, human | >95.0% | 50UG
Recombinant human HLA-A*02:01 monomer complexed with beta-2 microglobulin and the PRAME-derived peptide SLLQHLIGL. Produced in HEK293 cells and supplied with C-terminal Avi and 8xHis tags, this high-purity monomer is intended for antigen presentation research, epitope mapping, and T cell assays.
- Monomeric HLA-A*02:01 complex with PRAME peptide SLLQHLIGL for epitope-specific assays.
- Produced in HEK293 cells for native folding and appropriate post-translational modifications.
- C-terminal Avi tag for biotinylation and C-terminal 8xHis tag for purification and detection.
- Purity >95.0% as determined by reducing SDS-PAGE.
- Available in small, pre-measured sizes suitable for T cell assays and ELISPOT.
- Stable when stored at -20°C; aliquot and freeze at -20°C or -80°C for extended storage.
Aobchem 3-(Ethylthio)-N N-dimethylbenzenamine | 97% | CAS 91330-03-9 | C10H15NS | 1g
3-(Ethylthio)-N N-dimethylbenzenamine | 97% | CAS 91330-03-9 | C10H15NS | 1g
Aobchem 4-Benzyloxy-2 6-difluorobenzoic acid methyl ester | ≥97% | CAS 1993479-31-4 | C15H12F2O3 | 1g
4-Benzyloxy-2 6-difluorobenzoic acid methyl ester | ≥97% | CAS 1993479-31-4 | C15H12F2O3 | 1g
Aobchem 4-(2-Methoxyethyl)benzoic acid | ≥95% | CAS 60835-91-8 | C10H12O3 | 250mg
4-(2-Methoxyethyl)benzoic acid | ≥95% | CAS 60835-91-8 | C10H12O3 | 250mg
Aobchem 2-Fluoro-4 5-dimethylbenzoic acid | ≥97% | CAS 1427427-79-9 | C9H9FO2 | 500mg
2-Fluoro-4 5-dimethylbenzoic acid | ≥97% | CAS 1427427-79-9 | C9H9FO2 | 500mg
Aobchem 4-(2-Methoxyethyl)benzoic acid | ≥95% | CAS 60835-91-8 | C10H12O3 | 1g
4-(2-Methoxyethyl)benzoic acid | ≥95% | CAS 60835-91-8 | C10H12O3 | 1g
Aobchem 5-Bromo-3-fluoro-2-methylbenzoic acid | ≥95% | CAS 1427433-28-0 | C8H6BrFO2 | 500mg
5-Bromo-3-fluoro-2-methylbenzoic acid | ≥95% | CAS 1427433-28-0 | C8H6BrFO2 | 500mg
Aobchem 3 5-Dibromo-2-fluorobenzoic acid | ≥97% | CAS 183065-73-8 | C7H3Br2FO2 | 1g
3 5-Dibromo-2-fluorobenzoic acid | ≥97% | CAS 183065-73-8 | C7H3Br2FO2 | 1g
Medchemexpress LLC 2-Amino-2'-chloro-5-nitrobenzophenone | 2011-66-7 | MFCD00792453 | ≥98.0% | 276.68 | 50 G
2-Amino-2'-chloro-5-nitrobenzophenone is a precursor used in the synthesis of benzodiazepines. It is also identified as a hydrolysis product of Clonazepam.
- Precursor in the synthesis of benzodiazepines
- Hydrolysis product of Clonazepam